ESSILORLUXOTTICA 1/2/O.N. Total Assets

Latest as of June 2026: €65.06 Billion EUR ≈ $76.06 Billion USD

ESSILORLUXOTTICA 1/2/O.N. total assets. Based on the latest financial reports, ESSILORLUXOTTICA 1/2/O.N. (ESLC) holds total assets worth €65.06 Billion EUR (≈ $76.06 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of ESSILORLUXOTTICA 1/2/O.N. for the company's overall valuation and market capitalisation.

Total Assets of ESSILORLUXOTTICA 1/2/O.N. (2021–2025)

Total assets of ESSILORLUXOTTICA 1/2/O.N. from 2021 to 2025. This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s total assets have evolved over time, based on quarterly financial data. See ESLC live share price for real-time trading data and today's change.

ESSILORLUXOTTICA 1/2/O.N. - Asset Composition Analysis

ESSILORLUXOTTICA 1/2/O.N. Total Assets Breakdown (December 2025)

ESSILORLUXOTTICA 1/2/O.N. total assets breakdown as of December 2025. ESSILORLUXOTTICA 1/2/O.N.'s total assets of €65.06 Billion consist of 18.8% current assets and 81.2% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 5.6%
Accounts Receivable €3.64 Billion 5.7%
Inventory €3.54 Billion 5.5%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €9.75 Billion 15.3%
Goodwill €31.01 Billion 48.5%

Asset Composition Trend (2021–2025)

This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is ESSILORLUXOTTICA 1/2/O.N.'s working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: ESSILORLUXOTTICA 1/2/O.N.'s current assets represent 18.8% of total assets in 2025, an increase from 15.6% in 2021.
  • Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, up from 5.5% in 2021.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, a decrease from 69.0% in 2021.
  • Asset Diversification: The largest asset category is goodwill at 48.5% of total assets.

ESSILORLUXOTTICA 1/2/O.N. Competitors by Total Assets

Key competitors of ESSILORLUXOTTICA 1/2/O.N. based on total assets are shown below.

Company Country Total Assets
SARTORIUS (UNSP.ADS)/1/5
F:SRT0
Germany €9.87 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
iRay Technology Co Ltd
SHG:688301
China CN¥11.33 Billion
Guangzhou Improve Med Instrument
SHE:300030
China CN¥1.02 Billion
Medeon Biodesign
TWO:6499
Taiwan NT$1.55 Billion
Ansell Ltd
AU:ANN
Australia AU$3.39 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
SDI Ltd
AU:SDI
Australia AU$135.84 Million

ESSILORLUXOTTICA 1/2/O.N. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.89 0.97 0.88
Quick Ratio 0.59 0.67 0.62
Cash Ratio 0.00 0.00 0.00
Working Capital €-1.40 Billion €-362.00 Million €-1.31 Billion

ESSILORLUXOTTICA 1/2/O.N. - Advanced Valuation Insights

This section examines the relationship between ESSILORLUXOTTICA 1/2/O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.73
Latest Market Cap to Assets Ratio 1.06
Asset Growth Rate (YoY) -0.6%
Total Assets €63.90 Billion
Market Capitalization $67.43 Billion USD

Valuation Analysis

Above Book Valuation: The market values ESSILORLUXOTTICA 1/2/O.N.'s assets above their book value (1.06x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: ESSILORLUXOTTICA 1/2/O.N.'s assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for ESSILORLUXOTTICA 1/2/O.N. (2021–2025)

The table below shows the annual total assets of ESSILORLUXOTTICA 1/2/O.N. from 2021 to 2025.

Year Total Assets Change
2025-12-31 €63.90 Billion
≈ $74.70 Billion
-0.57%
2024-12-31 €64.26 Billion
≈ $75.13 Billion
+6.18%
2023-12-31 €60.52 Billion
≈ $70.76 Billion
-0.06%
2022-12-31 €60.56 Billion
≈ $70.80 Billion
+1.93%
2021-12-31 €59.41 Billion
≈ $69.46 Billion
--

About ESSILORLUXOTTICA 1/2/O.N.

F:ESLC Germany Medical Instruments & Supplies
Market Cap
$93.85 Billion
€80.28 Billion EUR
Market Cap Rank
#421 Global
#82 in Germany
Share Price
€87.50
Change (1 day)
-1.13%
52-Week Range
€68.50 - €160.00
All Time High
€160.00
About

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Ni… Read more